| Lastest Insider Transactions Of Syndax Pharmaceuticals Inc ( SNDX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| SNDX | Syndax Pharmaceuticals Inc | Botwood Nicholas A.J. | Head of R&D, CMO | 2026-06-11 | Sell | 65,515 | 18.07 | 1,183,643 | 2026-06-12 17:09:52 |
| SNDX | Syndax Pharmaceuticals Inc | Botwood Nicholas A.J. | Head of R&D, CMO | 2026-06-11 | Option Exercise | 53,750 | 13.82 | 742,825 | 2026-06-12 17:09:52 |
| SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Chief Executive Officer | 2026-02-09 | Sell | 17,159 | 21.03 | 360,819 | 2026-02-10 09:00:18 |
| SNDX | Syndax Pharmaceuticals Inc | Goldan Keith A. | Chief Financial Officer | 2026-02-09 | Sell | 3,410 | 21.03 | 71,705 | 2026-02-10 08:59:55 |
| SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Chief Executive Officer | 2026-02-04 | Sell | 7,412 | 20.62 | 152,835 | 2026-02-06 17:54:06 |
| SNDX | Syndax Pharmaceuticals Inc | Goldan Keith A. | Chief Financial Officer | 2026-02-04 | Sell | 2,082 | 20.62 | 42,931 | 2026-02-06 17:53:43 |
| SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Chief Executive Officer | 2025-09-08 | Sell | 157,307 | 16.41 | 2,582,021 | 2025-09-08 18:45:31 |
| SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Chief Executive Officer | 2025-09-08 | Option Exercise | 157,307 | 10.90 | 1,714,646 | 2025-09-08 18:45:31 |
| SNDX | Syndax Pharmaceuticals Inc | Podlesak Dennis | Directior | 2025-08-14 | Sell | 57,600 | 15.19 | 875,100 | 2025-08-18 17:02:20 |
| SNDX | Syndax Pharmaceuticals Inc | Podlesak Dennis | Directior | 2025-08-14 | Option Exercise | 57,600 | 7.20 | 414,720 | 2025-08-18 17:02:20 |
| SNDX | Syndax Pharmaceuticals Inc | Goldan Keith A. | Chief Financial Officer | 2025-07-16 | Sell | 1,296 | 9.29 | 12,033 | 2025-07-18 16:30:06 |
| SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Chief Executive Officer | 2025-07-16 | Sell | 7,534 | 9.29 | 69,953 | 2025-07-18 16:30:04 |
| SNDX | Syndax Pharmaceuticals Inc | Goldan Keith A. | Chief Financial Officer | 2025-05-19 | Buy | 3,000 | 0.00 | 0 | 2025-05-19 16:04:07 |
| SNDX | Syndax Pharmaceuticals Inc | Botwood Nicholas A.J. | Head of R&D, CMO | 2025-05-16 | Buy | 11,765 | 8.99 | 105,826 | 2025-05-19 16:03:03 |
| SNDX | Syndax Pharmaceuticals Inc | Huber Martin H. Jr. | Directior | 2025-05-19 | Buy | 5,000 | 8.99 | 44,950 | 2025-05-19 16:02:03 |
| SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Chief Executive Officer | 2025-03-14 | Option Exercise | 6,074 | 7.20 | 43,733 | 2025-03-17 06:01:11 |
| SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Chief Executive Officer | 2025-03-04 | Sell | 7,814 | 15.05 | 117,564 | 2025-03-06 16:10:30 |
| SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Chief Executive Officer | 2025-03-04 | Option Exercise | 7,814 | 7.20 | 56,261 | 2025-03-06 16:10:30 |
| SNDX | Syndax Pharmaceuticals Inc | Goldan Keith A. | Chief Financial Officer | 2025-02-10 | Sell | 3,777 | 15.50 | 58,559 | 2025-02-12 17:16:46 |
| SNDX | Syndax Pharmaceuticals Inc | Goldan Keith A. | Chief Financial Officer | 2025-02-10 | Sell | 3,777 | 15.50 | 58,559 | 2025-02-12 17:16:46 |
| SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Chief Executive Officer | 2025-02-10 | Sell | 13,288 | 15.50 | 206,017 | 2025-02-12 17:15:20 |
| SNDX | Syndax Pharmaceuticals Inc | Gallagher Neil | President, Head of R&D | 2025-02-10 | Sell | 4,618 | 15.50 | 71,597 | 2025-02-12 17:13:24 |
| SNDX | Syndax Pharmaceuticals Inc | Goldan Keith A. | Chief Financial Officer | 2024-06-14 | Buy | 1,250 | 20.03 | 25,037 | 2024-06-17 09:26:27 |
| SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Directior | 2023-08-09 | Sell | 52,855 | 18.27 | 965,402 | 2023-08-10 06:50:32 |
| SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Directior | 2023-08-09 | Option Exercise | 52,855 | 8.77 | 463,538 | 2023-08-10 06:50:32 |
| SNDX | Syndax Pharmaceuticals Inc | Meury William | Directior | 2023-08-02 | Sell | 83,000 | 20.46 | 1,697,810 | 2023-08-03 09:12:02 |
| SNDX | Syndax Pharmaceuticals Inc | Meury William | Directior | 2023-08-02 | Option Exercise | 83,000 | 8.02 | 665,250 | 2023-08-03 09:12:02 |
| SNDX | Syndax Pharmaceuticals Inc | Meury William | Directior | 2023-08-02 | Sell | 83,000 | 20.46 | 1,697,810 | 2023-08-03 09:12:02 |
| SNDX | Syndax Pharmaceuticals Inc | Meury William | Directior | 2023-08-02 | Option Exercise | 83,000 | 8.02 | 665,250 | 2023-08-03 09:12:02 |
| SNDX | Syndax Pharmaceuticals Inc | Goldan Keith A. | Chief Financial Officer | 2023-06-13 | Sell | 577 | 22.31 | 12,873 | 2023-06-14 16:20:09 |
| SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Directior | 2023-06-09 | Sell | 52,855 | 21.18 | 1,119,421 | 2023-06-09 17:32:28 |
| SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Directior | 2023-06-09 | Option Exercise | 52,855 | 7.66 | 404,787 | 2023-06-09 17:32:28 |
| SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Directior | 2023-05-09 | Sell | 52,855 | 21.41 | 1,131,478 | 2023-05-10 16:11:57 |
| SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Directior | 2023-05-09 | Option Exercise | 52,855 | 6.38 | 337,215 | 2023-05-10 16:11:57 |
| SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Directior | 2023-04-10 | Sell | 52,855 | 19.53 | 1,032,237 | 2023-04-12 16:03:51 |
| SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Directior | 2023-04-10 | Option Exercise | 52,855 | 6.38 | 337,215 | 2023-04-12 16:03:51 |
| SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | President, Head of R&D | 2023-03-13 | Sell | 52,854 | 22.53 | 1,190,674 | 2023-03-14 16:42:48 |
| SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | President, Head of R&D | 2023-03-13 | Option Exercise | 52,854 | 6.38 | 337,209 | 2023-03-14 16:42:48 |
| SNDX | Syndax Pharmaceuticals Inc | Ordentlich Peter | Chief Scientific Officer | 2023-02-15 | Sell | 25,000 | 25.84 | 646,093 | 2023-02-17 18:09:58 |
| SNDX | Syndax Pharmaceuticals Inc | Ordentlich Peter | Chief Scientific Officer | 2023-02-15 | Option Exercise | 25,000 | 6.95 | 173,791 | 2023-02-17 18:09:58 |
| SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Chief Executive Officer | 2023-02-06 | Sell | 5,959 | 27.64 | 164,697 | 2023-02-08 16:49:37 |
| SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Chief Executive Officer | 2023-02-06 | Option Exercise | 5,959 | 6.38 | 38,018 | 2023-02-08 16:49:37 |
| SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | President, Head of R&D | 2023-02-06 | Sell | 52,854 | 26.83 | 1,417,909 | 2023-02-08 16:49:08 |
| SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | President, Head of R&D | 2023-02-06 | Option Exercise | 52,854 | 6.38 | 337,209 | 2023-02-08 16:49:08 |
| SNDX | Syndax Pharmaceuticals Inc | Ordentlich Peter | Chief Scientific Officer | 2023-01-31 | Sell | 69 | 28.43 | 1,962 | 2023-02-03 16:59:20 |
| SNDX | Syndax Pharmaceuticals Inc | Legault Pierre | Directior | 2023-01-12 | Sell | 39,000 | 26.84 | 1,046,782 | 2023-01-13 16:44:07 |
| SNDX | Syndax Pharmaceuticals Inc | Legault Pierre | Directior | 2023-01-12 | Option Exercise | 39,000 | 11.05 | 430,980 | 2023-01-13 16:44:07 |